Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer

References

• Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203.
   PubMed Web of Science ®Google Scholar
• Nie S, Yang G, Lu H. Current molecular targeted agents for advanced gastric cancer. Onco Targets Ther. 2020;13:4075–4088.
   PubMed Web of Science ®Google Scholar
• Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.
   PubMed Web of Science ®Google Scholar
• Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–279.
   PubMed Web of Science ®Google Scholar
• Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–542.
   PubMed Web of Science ®Google Scholar
• Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 1977;87(3):293–298.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang C, Sun H, et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform. 2021;22(2):1706–1728.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu J, Ma J, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18(1):116.
   PubMed Web of Science ®Google Scholar
• Chen L, Shan G. CircRNA in cancer: fundamental mechanism and clinical potential. Cancer Lett. 2021;505:49–57.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Li W, et al. Knockdown of cir_RNA PVT1 elevates gastric cancer cisplatin sensitivity via sponging miR-152-3p. J Surg Res. 2021;261:185–195.
   PubMed Web of Science ®Google Scholar
• Peng L, Sang H, Wei S, et al. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Mol Cancer. 2020;19(1):156.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang Q, Guan B. Circ_0110805 knockdown enhances cisplatin sensitivity and inhibits gastric cancer progression by miR-299-3p/ENDOPDI axis. Onco Targets Ther. 2020;13:11445–11457.
   PubMed Web of Science ®Google Scholar
• Papatsirou M, Artemaki PI, Scorilas A, et al. The role of circular RNAs in therapy resistance of patients with solid tumors. Per Med. 2020;17(6):469–490.
   PubMedGoogle Scholar
• Ouyang Y, Li Y, Huang Y, et al. CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2. J Cell Physiol. 2019;234(7):10458–10469.
   PubMed Web of Science ®Google Scholar
• Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21–37.
   PubMed Web of Science ®Google Scholar
• Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):dmm047662.
   PubMed Web of Science ®Google Scholar
• Mirzaei S, Gholami MH, Hushmandi K, et al. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol. 2022;15(1):18.
   PubMed Web of Science ®Google Scholar
• Mei J, Liu G, Li R, et al. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis. Biosci Rep. 2021;41(12):SR20211885.
   Web of Science ®Google Scholar
• Lin J, Qin H, Han Y, et al. CircNRIP1 modulates the miR-515-5p/IL-25 axis to control 5-Fu and cisplatin resistance in nasopharyngeal carcinoma. Drug Des Dev Ther. 2021;15:323–330.
   PubMed Web of Science ®Google Scholar
• Yan J, Xu H. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma. Bioengineered. 2021;12(2):12420–12430.
   PubMed Web of Science ®Google Scholar
• Wang D, Liu K, Chen E. LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer. Cell Mol Biol Lett. 2020;25:4.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang L, Lu M. Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway. Bioengineered. 2021;12(2):11909–11921.
   PubMed Web of Science ®Google Scholar
• Song H, Li H, Ding X, et al. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis. Int J Oncol. 2020;57(6):1333–1347.
   PubMed Web of Science ®Google Scholar
• Wang G, Sun D, Li W, et al. CircRNA_100290 promotes GC cell proliferation and invasion via the miR-29b-3p/ITGA11 axis and is regulated by EIF4A3. Cancer Cell Int. 2021;21(1):324.
   PubMed Web of Science ®Google Scholar
• Bagrodia A, Lee BH, Lee W, et al. Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors. J Clin Oncol. 2016;34(33):4000–4007.
   PubMed Web of Science ®Google Scholar
• Peng QS, Cheng YN, Zhang WB, et al. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit hippo signaling pathway. Cell Death Dis. 2020;11(2):112.
   PubMed Web of Science ®Google Scholar
• Shen C, Wu Z, Wang Y, et al. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer Med. 2020;9(11):3885–3903.
   PubMed Web of Science ®Google Scholar
• Huang DW, Huang M, Lin XS, et al. CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma. Onco Targets Ther. 2017;10:3817–3825.
   PubMed Web of Science ®Google Scholar
• Cocetta V, Ragazzi E, Montopoli M. Links between cancer metabolism and cisplatin resistance. Int Rev Cell Mol Biol. 2020;354:107–164.
   PubMed Web of Science ®Google Scholar
• Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378.
   PubMed Web of Science ®Google Scholar
• Mu Q, Lv Y, Luo C, et al. Research progress on the functions and mechanism of circRNA in cisplatin resistance in tumors. Front Pharmacol. 2021;12:709324–709324.
   PubMed Web of Science ®Google Scholar
• Yu Q, Liu P, Han G, et al. CircRNA circPDSS1 promotes bladder cancer by down-regulating miR-16. Biosci Rep. 2020;40(1):BSR20191961.
   PubMedGoogle Scholar
• Liu L, Dong T, Sheng J. Propofol suppresses gastric cancer progression by regulating circPDSS1/miR-1324/SOX4 axis. Cancer Manag Res. 2021;13:6031–6043.
   PubMed Web of Science ®Google Scholar
• Kong FB, Deng QM, Deng HQ, et al. Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway. Mol Med Rep. 2020;22(2):1558–1566.
   PubMed Web of Science ®Google Scholar
• Fu Z, Xu Y, Chen Y, et al. Construction of miRNA-mRNA-TF regulatory network for diagnosis of gastric cancer. Biomed Res Int. 2021;2021:9121478.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. Onco Targets Ther. 2020;13:2067–2092.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu H, Zeng Q, et al. Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis. Cancer Cell Int. 2020;20:171.
   PubMed Web of Science ®Google Scholar
• Li L, Lai Q, Zhang M, et al. Long non-coding RNA DLGAP1-AS1 promotes the progression of gastric cancer via miR-515-5p/MARK4 axis. Braz J Med Biol Res. 2021;54(8):e10062.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang X, Huang H, et al. Hsa_circ_0067997 promotes the progression of gastric cancer by inhibition of miR-515-5p and activation of X chromosome-linked inhibitor of apoptosis (XIAP). Artif Cells Nanomed Biotechnol. 2019;47(1):308–318.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Wang D, Ding Y, et al. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p. Biotechnol Lett. 2021;43(2):339–351.
   PubMed Web of Science ®Google Scholar
• Park J, Ko YS, Yoon J, et al. The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway. Gastric Cancer. 2014;17(3):423–430.
   PubMed Web of Science ®Google Scholar